학술논문
S173: T-CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM THE MODE OF ACTION OF RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Document Type
article
Author
I. Dekhtiarenko; I. Lelios; J. Attig; N. Sleiman; D. Lazzaro; I. Clausen; N. Gräfe; H.-J. Helms; E. Schindler; S. Belli; T. Fauti; J. Eckmann; P. Umana; W. Jacob; M. Schneider; C. Hasselbalch Riley; M. Hutchings; S.-S. Yoon; Y Koh; S. Manier; T. Facon; S. J. Harrison; J. Er; F. Volzone; A. Pinto; C. Montes; E. M. Ocio; A. Alfonso-Pierola; P. Rodríguez Otero; F. Offner; A. Guidetti; P. Corradini; C. Titouan; C. Hulin; C. Touzeau; P. Moreau; R. Popat; S. Leong; R. Mazza; C. Carlo-Stella; A.-M. E. Bröske
Source
HemaSphere, Vol 6, Pp 74-75 (2022)
Subject
Language
English
ISSN
2572-9241
00008435
00008435